Delivering Enhanced
Topical Products
Sol-Gel develops innovative specialty pharmaceuticals for the dermatology market. With state-of-the-art, patented delivery systems, Sol-Gel strives to improve the efficacy, tolerability and safety of topical drugs.
 
 
 
 
INNOVATION
Innovative dermatological drug products that demonstrate significantly improved efficacy and tolerability profiles
 
   
   PORTFOLIO
Innovative topical drugs including first-in-class non-antibiotic topical drug SGT-VD-54 for treatment of rosacea that has met endpoint Phase II trials
 
  Terms of Use    |  Copyright Policy   |  Contact Us